MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
90.22
+0.38
+0.42%
After Hours: 90.49 +0.27 +0.30% 17:00 11/05 EST
OPEN
89.64
PREV CLOSE
89.84
HIGH
90.39
LOW
89.01
VOLUME
3.86M
TURNOVER
--
52 WEEK HIGH
90.71
52 WEEK LOW
60.75
MARKET CAP
112.32B
P/E (TTM)
110.15
1D
5D
1M
3M
1Y
5Y
1D
Arcellx issues updates on anito-cel clinical trials
Seeking Alpha · 9h ago
Gilead's Kite To Highlight CAR T-Cell Therapy Portfolio At ASH 2024, Including Survival Outcomes In Both Clinical Trials And The Real-World
Benzinga · 9h ago
KITE TO HIGHLIGHT INDUSTRY-LEADING CAR T-CELL THERAPY PORTFOLIO AT ASH 2024, INCLUDING POSITIVE SURVIVAL OUTCOMES IN BOTH CLINICAL TRIALS AND THE REAL-WORLD
Reuters · 9h ago
Arcus Biosciences announces results from Part 1 of ARC-10 trial
TipRanks · 9h ago
Gilead Sciences's Earnings: A Preview
Benzinga · 9h ago
Gilead Science to Report Q3 Earnings: What's in the Cards?
NASDAQ · 1d ago
Gilead call volume above normal and directionally bullish
TipRanks · 1d ago
Jefferies Remains a Buy on Gilead Sciences (GILD)
TipRanks · 1d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including human immunodeficiency virus (HIV), viral hepatitis, coronavirus disease 2019 (COVID-19) and cancer. It is focused on the discovery, development and commercialization of medicines in areas of unmet medical need. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada, Truvada for PrEP, Tybost, Veklury, Vemlidy, Viread, Vosevi, Yescarta and Zydelig. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, and Domvanalimab and zimberelimab, and seladelpar. Seladelpar shall be used for the treatment of primary biliary cholangitis (PBC), including pruritus. The Company operates in more than 35 countries.

Webull offers Gilead Sciences, Inc. stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.